XTX Topco’s Viking Therapeutics VKTX Stock Holding History

XTX Topco’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95M	Buy	+50,091	New	+$1.62M	0.03%	1125
2025 Q4	–	Sell	-41,915	Closed	-$1.1M	–	3849
2025 Q3	$1.1M	Buy	41,915 +5,716	+16%	+$171K	0.06%	516
2025 Q2	$959K	Buy	+36,199	New	+$953K	0.04%	689
2025 Q1	–	Sell	-13,251	Closed	-$533K	–	3171
2024 Q4	$533K	Buy	13,251 +9,129	+221%	+$521K	0.04%	720
2024 Q3	$261K	Sell	4,122 -44,350	-91%	-$2.6M	0.02%	1279
2024 Q2	$2.57M	Buy	+48,472	New	+$3.18M	0.22%	73
2023 Q4	–	Sell	-38,184	Closed	-$423K	–	2195
2023 Q3	$423K	Buy	+38,184	New	+$546K	0.07%	497
2022 Q3	–	Sell	-29,827	Closed	-$86K	–	1408
2022 Q2	$86K	Buy	+29,827	New	+$73.8K	0.04%	681
2022 Q1	–	Sell	-19,363	Closed	-$89K	–	971
2021 Q4	$89K	Buy	+19,363	New	+$109K	0.05%	482
2021 Q3	–	Sell	-24,841	Closed	-$149K	–	1085
2021 Q2	$149K	Buy	24,841 +10,208	+70%	+$60.6K	0.05%	605
2021 Q1	$93K	Buy	+14,633	New	+$103K	0.05%	576

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

XTX Topco's VKTX Position: Q2 2026 in Review

XTX Topco opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 50,091 shares worth $1.95M. The stake represents 0.03% of the portfolio and ranks #1125 among its holdings. This is a return to the name: XTX Topco previously reported a position in VKTX as recently as Q3 2025.

XTX Topco first reported a position in VKTX in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.57M in Q2 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

XTX Topco held 50,091 shares of Viking Therapeutics worth $1.95M as of Q2 2026.
Viking Therapeutics was a new XTX Topco position in Q2 2026.
Viking Therapeutics made up 0.03% of XTX Topco's portfolio in Q2 2026, its #1125 holding.
XTX Topco first reported a position in Viking Therapeutics in Q1 2021 and has held it in 11 quarters since.
XTX Topco's Viking Therapeutics position peaked at $2.57M in Q2 2024.
436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.